Open Access

Association between Helicobacter pylori infection and delayed growth in children: A meta‑analysis

  • Authors:
    • Shuchun Wei
    • Yini Dang
    • Lei Peng
    • Xuan Li
    • Liming Tang
    • Guoxin Zhang
  • View Affiliations

  • Published online on: April 9, 2020     https://doi.org/10.3892/etm.2020.8654
  • Pages: 3814-3828
  • Copyright: © Wei et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Helicobacter pylori (H. pylori) infection is associated with extra‑gastrointestinal diseases in children. The present study aimed to investigate the potential association between H. pylori infection and growth in children. The PubMed, Exerpta Medica dataBASE, Cochrane Library and Chinese Biomedical Literature Database databases were comprehensively searched for relevant publications dated between January 1st 1994 and January 1st 2019. Delayed childhood growth was defined according to the age‑appropriate criteria in the World Health Organization Child Growth Charts (2006 edition). The odds ratios (ORs) and 95% CIs were pooled using the fixed‑effects model and subgroup and sensitivity analyses were performed using Review Manager (version 5.3; Cochrane) and STATA (version 12.0; StataCorp LP) software. A total of 15 observational studies comprising 4,199 subjects were included in the present study. A higher frequency of delayed growth was observed in H. pylori‑positive children compared with that in H. pylori‑negative children (OR, 1.51; 95% CI, 1.28‑1.78), particularly for linear growth (OR, 1.63; 95% CI, 1.32‑2.00). The aforementioned association was only observed when H. pylori infection was detected using 13C‑urea breath tests (OR, 1.72; 95% CI, 1.22‑2.40) or serum IgG antibodies targeted against H. pylori (OR, 1.81; 95% CI, 1.35‑2.44). H. pylori infection was also associated with delayed childhood growth in studies with a H. pylori prevalence of ≤30% (OR, 1.71; 95% CI, 1.31‑2.23) or >30% but not >50% (OR, 1.43; 95% CI, 1.10‑1.86). The association between infection and growth was only statistically significant in the cross‑sectional (OR, 1.43; 95% CI, 1.18‑1.73) and case‑control (OR, 1.81; 95% CI, 1.23‑2.67) studies. No significant heterogeneity among studies was identified in the present analysis. According to Begg's and Egger's linear regression methods for funnel plots and quantification assessments, no publication bias was identified. The trim and fill method further suggested that H. pylori‑positive children were prone to delayed linear growth. Therefore, the present study suggested that preventing and detecting H. pylori infection in children may be critical to ensure normal growth and development during childhood.

Introduction

Helicobacter pylori (H. pylori) is a helical, gram-negative micro-aerobic bacterium that colonises the stomach (1). It is the major pathogen associated with gastritis, peptic ulcers and gastric cancer (2-4). Certain H. pylori genotypes are risk factors for gastric disease, e.g. the vacuolating toxin A-positive and cytotoxin-associated gene A-positive genotypes (5). H. pylori-positive children present with clinical manifestations that vary widely from H. pylori-positive adults, including iron deficiency anaemia (6). Furthermore, H. pylori-positive children display no adverse digestive system symptoms, except occasional abdominal pain or duodenal ulcers during late childhood. By contrast, H. pylori-positive adults are susceptible to various clinically significant diseases, including ulcers and cancer of the gastrointestinal system (7-10). It has been reported that successful eradication of H. pylori during childhood increases growth and restores serum acylated ghrelin levels in children (11). However, the European and North American Gastroenterology and Nutrition Society does not recommend the detection and treatment of H. pylori infection in children due to the low efficacy of the currently recommended H. pylori eradication therapy and the lack of broad availability of culture or molecular-based testing (12). Therefore, optimised vaccine strategies and a high-performance first-line treatment based on antimicrobial susceptibility profiles are urgently required for the efficient treatment of H. pylori infection in children (12-15).

A previous study reported a higher percentage of delayed growth, defined according to the World Health Organization (WHO) age-appropriate criteria (2006 edition) (16,17), in children infected with H. pylori compared with controls (18), while other studies have reported no effect of H. pylori infection on the growth of children (17-19). Thomas et al (19) reported that the effects of H. pylori colonisation on malnutrition and delayed growth during early infancy (age, 5-8 years) did not persist into late childhood. Conversely, Perri et al (20) and Fialho et al (21) reported an association between short stature and H. pylori infection in older children aged between 8 and 14 years. Furthermore, the effects of H. pylori infection on the growth and development of female children have been reported to be associated with puberty (22). Tasar et al (23) reported that H. pylori seroprevalence was higher in children with delayed growth compared with the control group. Therefore, the association between the H. pylori infection in childhood and delayed growth remains a topic of debate. Routine screening for H. pylori in children under 14 years of age is not recommended at present and the Fifth National H. Pylori Infection Consensus Report of China only recommended that children with peptic ulcers should undergo examination for H. pylori (24). As an intragastric infection that begins during infancy (25), the effective eradication of H. pylori in a paediatric population is critical (13). The meta-analysis performed in the present study comprehensively assessed all available published studies to determine the possible association between H. pylori infection and delayed growth during childhood.

Materials and methods

Literature search

The Meta-analyses of Observational Studies in Epidemiology and Preferred Reporting Items for Systemic Reviews and Meta-Analyses statement guidelines were followed for the literature search in the present study (26,27). PubMed, Exerpta Medica dataBASE, Cochrane Library and the Chinese Biomedical Literature Database were searched for relevant literature using the following terms: ‘Helicobacter pylori’ [medical subject headings (MeSH) terms] or ‘Helicobacter pylori’ or ‘H. pylori’, and ‘Growth Disorders (MeSH Terms) or ‘disorder, growth or ‘growth disorder, ‘stunted growth or ‘growth, stunted or ‘stunting, ‘thrive, failure to or ‘Failure to Thrive (MeSH Terms), or ‘growth retardation or ‘growth restriction. Furthermore, the lists of references all the eligible studies were manually reviewed to identify additional studies.

Inclusion and exclusion criteria

Case-control, cohort and cross-sectional observational studies were included in the present study. All relevant full texts assessing the effect of H. pylori infection on delayed growth in children published between January 1st 1994 and January 1st 2019 were included in the present meta-analysis. Case reports, review articles, meta-analyses, duplicate reports, letters to the editor, commentaries, authors' replies and abstracts presented at conferences were excluded from the present study. Articles with insufficient data were also excluded from the present study after two reviewers performed an independent screening of the abstracts and full texts (SW and YD). Any disagreements were resolved by a third reviewer (LP).

Quality assessment

To ensure the quality of the meta-analysis, quality assessments of each of the included articles were performed. Quality evaluation of the case-control and cohort studies was performed using the Newcastle-Ottawa Scale (28). The methodological quality of the cross-sectional studies was evaluated using the 11-item checklist recommended by the Agency for Healthcare Research and Quality that was applied by a previous meta-analysis (29). Higher scores indicated higher quality articles; therefore, articles with a final score of ≥7 points were included in the present study (28,29).

Data extraction

The basic data were extracted from the studies by two reviewers (SW and YD) and included the following: First author, year of publication, country/continent, sample size, age and gender of participants, prevalence of H. pylori infection, study design, H. pylori detection method, type of delayed growth, definition of delayed growth and adjustment for confounders. Delayed growth was defined according to the WHO age-appropriate criteria (2006 edition) (16,17). The number of children with delayed growth and healthy participants in the H. pylori-positive and H. pylori-negative groups was also recorded.

Statistical analysis

The potential risk of delayed growth in children infected with H. pylori was evaluated using a fixed-effects model to estimate the odds ratio (OR) and 95% confidence intervals (CI). Statistical heterogeneity was assessed using the χ2 test and I2 index. P<0.10 and I2>50% were considered to indicate statistically significant heterogeneity. I2 values of 0-25, 26-50, 50-75 and >75% were considered to indicate no, low, medium and high heterogeneity, respectively (30).

Subgroup analyses were performed based on country/continent, H. pylori prevalance, study design, H. pylori detection method, type of delayed growth and confounder adjustment. Furthermore, sensitivity analyses were performed to assess whether removing any single study at a later stage affected the primary outcome of the meta-analysis performed in the present study. Begg's and Egger's linear regression were performed to assess publication bias, as evaluated by funnel plots. Finally, the credibility of the results was estimated using the trim and fill method (31). Data analyses were performed using Review Manager (version 5.3; Cochrane) and STATA (version 12.0; StataCorp LP) softwares.

Results

Baseline characteristics

Of the 488 records initially retrieved, 44 were duplicates and the remaining 444 articles were screened based on titles and abstracts, of which 390 irrelevant studies were excluded. An additional 38 studies were excluded due to insufficient data. Following quality assessment of the remaining 16 observational studies, a total of 15 studies with a quality assessment score of ≥7 (Tables I-III) were included in the present study (Fig. 1), including two cohort (18,32), eight cross-sectional (20,21,33-38) and five case-control (39-43) studies.

The included articles, published between January 1st 1994 and January 1st 2019, comprised 1,371 H. pylori-positive and 2,828 H. pylori-negative children. Delayed growth was reported in 454 (33.11%) H. pylori-positive children and 761 (26.91%) H. pylori-negative children. The major characteristics of the included studies are presented in Table IV.

Table IV

Baseline characteristics of the included studies.

Table IV

Baseline characteristics of the included studies.

Author (year)Country, continentStudy designSample sizeAge (years)Males/femaleDetection methodType of delayed growth(Delayed growth group H. pylori +/-)Control group (H. pylori +/-)H. pylori prevalence (%)Definition of delayed growthQuality score(Refs.)
Raymond (1994)France, EuropeCohort1510-16N/ARapid urease testHeight and weight21/1756/5750.99Absence of growth hormone deficit7(32)
Perri (1997)Italy, Europe Cross-Sectional2163-14N/A13C-UBTHeight8/1341/15422.69Below the 25th centile value for height8(20)
Oderda (1998)Italy, EuropeCase-control2685-13170/98Serum H. pylori IgG antibodiesHeight27/10718/11616.79Below the 3rd centile value of height8(39)
Cacciari (1999)Italy, EuropeCase-control3382-16169/169Serum H. pylori IgG antibodiesHeight18/13813/1699.17Stature below the 3rd percentile for the corresponding age7(40)
Choe (2000)Korea, Asia Cross-sectional37510-15205/170Serum H. pylori IgG antibodiesHeight and weight18/6345/24916.80Below the 25th centile values for height or weight8(33)
Buyukgebiz (2001)Turkey, AsiaCase-control56Mean 14.53±1.12N/ASerum H. pylori IgG antibodiesHeight and weight16/812/2050.00Stature below parental height, retarded bone age (>2 SD below chronological age) and height velocity <25th percentile8(41)
Takahashi (2002)Japan, AsiaCase-control881-1657/31Serum H. pylori IgG antibodiesHeight6/353/4410.23Height of 1.5-2.0 SD or more below the mean height for age7(42)
Lin (2002)China, Asia Cross-sectional3562-7206/150Serum H. pylori IgG antibodiesHeight34/11130/18117.98Below the 25th centile value for height9(34)
Fialho (2007)Brazil, South America Cross-sectional3530.5-14180/17313C-UBTHeight122/7575/8155.81Below the 25th centile for height8(21)
Cherian (2009)Sudan, Burundi and Liberia, Africa Cross-sectional182Mean 8.0±4.393/89MFAT MUACWeight, height and32/11117/2281.87Z-score SD below normal (correlating to 5th centile)<1.648(35)
Gulcan (2010)Turkey, Asia Cross-sectional4906-15229/261Rapid urease testHeight and weight51/45180/21447.14Height and BMI SDS below the 5th percentile8(36)
Mendoza (2014)Mexico, North America Cross-Sectional6416-13N/AAt least one of three tests with postive resultsaHeight66/95172/30837.13Z-score of height for age <-1 SD8(37)
Janjetic (2015)Argentina, South America Cross-Sectional5254-16233/29213C-UBTHeight and weight6/13126/38025.14Height, weight or BMI-for-age below the 3rd SD9(38)
Chiu (2017)Australia, OceaniaCase-control1064-1864/4213C-UBTHeight and weight9/1722/5829.25Height or weight-for-age below the 15th percentile value7(43)
Benavides-Ward (2018)Peru, South AmericaCohort566-1229/27PCR amplification of the 23S rRNA geneHeight20/137/1448.212.2 SD below the Z-score of height-for-age7(18)

[i] a13C-UBT, antibodies against H. pylori whole-cell and CagA antigens. H. pylori, Helicobacter pylori; UBT, urea breath test; IgG, immunoglobulin G; MFAT, monoclonal faecal antigen enzyme immunoassay testing; MUAC, mid-upper arm circumferences; BMI, body mass index; SDS, standard deviation score; rRNA, ribosomal RNA; CagA, cytotoxin-associated gene A.

Primary outcomes

The prevalence of delayed childhood growth in the H. pylori-positive group was significantly increased compared with that in the H. pylori-negative group (OR, 1.51; 95% CI, 1.28-1.78; P<0.00001), with no significant heterogeneity (χ2=13.34; I2=0%; PHeterogeneity=0.50; Fig. 2). The results indicated that there was a positive association between H. pylori infection and delayed childhood growth.

Subgroup analyses
Country/continent

The 15 observational studies included in the present study consisted of participants from all five continents (Europe, America, Asia, Africa and Oceania). Participants from Europe (OR, 1.61; 95% CI, 1.11-2.35; Z=2.49; P=0.01; I2=0%; PHeterogeneity=0.80), America (OR, 1.50; 95% CI, 1.16-1.94; Z=3.06; P=0.002; I2=2%; PHeterogeneity=0.38) and Asia (OR, 1.66; 95% CI, 1.25-2.20; Z=3.49; P=0.0005; I2=0%; PHeterogeneity=0.59) displayed an association between H. pylori infection and delayed childhood growth; however, no association was observed in participants from Africa and Oceania (OR, 0.83; 95% CI, 0.44-1.56; Z=0.58; P=0.56; I2=53%; PHeterogeneity=0.14; Fig. 3).

Prevalence of H. pylori infection

The prevalence of H. pylori infection varied among the included studies, ranging from 9.17-81.87% (Table IV). Delayed growth in children among studies with a H. pylori prevalence of ≤30% (OR, 1.71; 95% CI, 1.31-2.23; Z=3.93; P<0.0001; I2=0%; PHeterogeneity=0.99) or >30 but ≤50% (OR, 1.43; 95% CI, 1.10-1.86; Z=2.64; P=0.008; I2=34%; PHeterogeneity=0.21) was associated with H. pylori infection, with no significant heterogeneity (χ2=1.38; I2=0%; PHeterogeneity=0.50). However, there was no association between delayed growth and H. pylori infection in studies with a H. pylori prevalence prevalence of >50% (OR, 1.36; 95% CI, 0.97-1.90; Z=1.78; P=0.08; Fig. 4).

Study design

Of the three types of observational studies included in the present analysis, cross-sectional (OR, 1.43; 95% CI, 1.18-1.73; Z=3.68; P=0.0002) and case-control (OR, 1.81; 95% CI, 1.23-2.67; Z=3.00; P=0.003) studies displayed an association between H. pylori infection and delayed childhood growth. Cohort studies did not display any association between the two factors (OR, 1.64; 95% CI, 0.89-3.03; Z=1.58; P=0.11). The heterogeneity among the three subgroups was not significant (χ2=1.24; I2=0%; PHeterogeneity=0.54; Fig. 5).

H. pylori detection method

In the studies using 13C-urea breath tests (UBTs; OR, 1.72; 95% CI, 1.22-2.40; Z=3.14; P=0.002; I2=0%; PHeterogeneity=0.86) and serum IgG antibodies targeted against H. pylori (OR, 1.81; 95% CI, 1.35-2.44; Z=3.97; P<0.0001; I2=0%; PHeterogeneity=0.89) detection methods, an association between H. pylori infection and delayed childhood growth was detected. However, the studies using other detection methods did not display any association, including the rapid urease test (OR, 1.32; 95% CI, 0.90-1.94; Z=1.43; P=0.15; I2=0%; PHeterogeneity=0.88), monoclonal faecal antigen enzyme immunoassay testing (OR, 0.55; 95% CI, 0.24-1.25; Z=1.44; P=0.15), PCR amplification of the 23S ribosomal RNA gene (OR, 3.08; 95% CI, 0.98-9.67; Z=1.92; P=0.05) or at least one of three positive examinations [13C-UBT, antibodies to whole-cell H. pylori and cytotoxin-associated gene A (CagA) antigens; OR, 1.24; 95% CI, 0.86-1.79; Z=1.17; P=0.24; Fig. 6].

Measures of delayed growth. H. pylori

infection was associated with the incidence of delayed growth when the primary outcome was height (OR, 1.63; 95% CI, 1.32-2.00; Z=4.57; P<0.00001; I2=0%; PHeterogeneity=0.72), which suggested that delayed linear growth was associated with H. pylori infection. H. pylori infection was also associated with delayed growth when height and weight were collectively analysed as the primary outcome (OR, 1.33; 95% CI, 1.00-1.75; Z=1.99; P=0.05; I2=33%; PHeterogeneity=0.19). No association was observed when the height, weight and mid-upper arm circumference were collectively analysed as the primary outcome (OR, 1.39; 95% CI, 0.52-3.74; Z=0.66; P=0.51) and no heterogeneity was identified among these subgroup analyses (χ2=1.34; I2=0%; PHeterogeneity=0.51; Fig. 7).

Confounder adjustment

Subgroup analyses were performed based on confounder adjustment; four studies were adjusted for potential confounders and the pooled OR was 1.32 (95% CI, 1.02-1.70; Z=2.12; P=0.03) with no significant heterogeneity (I2=52%; PHeterogeneity=0.10). The pooled unadjusted OR value was 1.67 (95% CI, 1.34-2.07; Z=4.63; P<0.00001) for the remaining 11 studies, with no significant heterogeneity (I2=0%; PHeterogeneity=0.88). Therefore, the results suggested that H. pylori infection was associated with delayed childhood growth, regardless of the adjustment for potential confounders (Fig. 8).

Sensitivity analysis

Following the omission of one study at a time, the pooled OR values of the remaining studies ranged from 1.47-1.58 with insignificant heterogeneity (I2=0-2%; PHeterogeneity>0.10), and the upper and lower thresholds of the 95% CI were >1, indicating that none of the results were significantly altered by the removal of one article from the meta-analysis (PRemainders' effect<0.0001; Table V; Fig. 9).

Table V

Sensitivity analysis.

Table V

Sensitivity analysis.

Author (year)OR (95% CI)HeterogeneityRemainders' effect(Refs.)
Raymond (1994)1.52 (1.29-1.80)I2=1%; P=0.44Z=4.89; P<0.00001(32)
Perri (1997)1.49 (1.26-1.76)I2=0%; P=0.49Z=4.69; P<0.00001(20)
Oderda (1998)1.50 (1.27-1.78)I2=2%; P=0.43Z=4.68; P<0.00001(39)
Cacciari (1999)1.50 (1.27-1.77)I2=2%; P=0.43Z=4.71; P<0.00001(40)
Choe (2000)1.50 (1.27-1.78)I2=2%; P=0.42Z=4.68; P<0.00001(33)
Buyukgebiz (2001)1.48 (1.25-1.75)I2=0%; P=0.58Z=4.62; P<0.00001(41)
Takahashi (2002)1.50 (1.27-1.77)I2=0%; P=0.46Z=4.78; P<0.00001(42)
Lin (2002)1.48 (1.24-1.76)I2=0%; P=0.47Z=4.44; P<0.00001(34)
Fialho (2007)1.47 (1.23-1.75)I2=0%; P=0.47Z=4.22; P<0.0001(21)
Cherian (2009)1.57 (1.33-1.86)I2=0%; P=0.89Z=5.28; P<0.00001(35)
Gulcan (2010)1.53 (1.29-1.83)I2=0%; P=0.44Z=4.75; P<0.00001(36)
Mendoza (2014)1.58 (1.32-1.90)I2=0%; P=0.44Z=4.89; P<0.00001(37)
Janjetic (2015)1.51 (1.28-1.79)I2=2%; P=0.42Z=4.85; P<0.00001(38)
Chiu (2017)1.51 (1.28-1.79)I2=2%; P=0.42Z=4.85; P<0.00001(43)
Benavides-Ward (2018)1.48 (1.26-1.75)I2=0%; P=0.54Z=4.66; P<0.00001(18)

[i] OR, odds ratio.

Publication bias

The funnel plot analysis suggested that there may be a certain amount of publication bias, since the included studies were not distributed completely symmetrically in the funnel plots (Fig. 10A). To investigate the potential publication bias, the included studies were evaluated using the Begg's and Egger's linear regression tests. No significant publication bias was detected using Begg's (P>|z|=0.113) or Egger's (P>|t|=0.257) linear regression analyses (Fig. 10B). Furthermore, adjustment of the funnel plots by the trim and fill method did not alter the results and a statistically significant association between H. pylori infection and delayed childhood growth was still observed (P<0.0001), indicating that the results were stable and credible (Fig. 10C).

Discussion

To the best of our knowledge, the present study was the first to investigate the association between H. pylori infection and delayed childhood growth. Following searching and screening, low-quality studies (23) were excluded and fifteen observational studies involving 4,199 children were used for the meta-analysis performed in the present study. The likelihood of delayed childhood growth was significantly increased in H. pylori-positive children compared with that in H. pylori-negative children. A series of further analyses indicated that the results of the present study were credible and stable.

Delayed growth is the most significant nutritional problem worldwide, which leads to long-term effects and may occur in utero (44). The present study suggested that H. pylori infection may be a potential risk factor for delayed childhood growth, particularly linear growth; however, the specific underlying mechanisms require further investigation. It remains elusive whether delayed childhood growth is due to the direct effects of H. pylori-induced inflammation or indirect effects of the infection, e.g. anorexia, abdominal pain, malabsorption or diarrhoea. Therefore, delayed growth may be due to direct as well as indirect effects of H. pylori infection (45). The clinical outcomes of H. pylori infection are affected by a number of factors, including virulence, the host gastric mucosa and the environment (46).

Clinical symptoms of H. pylori infection vary between children and adults, with a lower incidence of gastroduodenal ulcers, gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma in children (47,48). H. pylori-induced gastric inflammation is less severe in children compared with that in adults, due to the decreased gastric type 17 T-helper cell/interleukin-17 response in children, which is associated with increased activity of the mucosal regulatory T cells (48). Therefore, the extra-digestive manifestations of H. pylori colonisation in children, including iron deficiency anaemia (6), cognitive function (49), type I diabetes mellitus (50), Henoch-Schonlein purpura (51) and delayed growth, require constant medical attention. H. pylori infection has been reported in numerous studies as a risk factor for delayed childhood growth (18,20,21,23,34,37,41), and of note, Yang et al (11) reported that eradication of H. pylori infection promotes growth in children. A retrospective study indicated that the prevalence of childhood gastric cancer may be reduced by decreasing the prevalence of H. pylori infection in adolescents and children (15). However, Dehghani et al (52) suggested that H. pylori infection did not affect the calculated standard deviation score (height and body mass index) (52). Cherian et al (35), Janjetic et al (38), Chiu et al (43) and Choe et al (33) reported that childhood growth and puberty are affected by iron deficiency anaemia and H. pylori infection, rather than H. pylori infection alone. Ortiz-Princz et al (46) revealed that early identification and intervention of H. pylori infection during childhood prevents further serious complications during adulthood, which is consistent with the results of the present study.

In the present meta-analysis, the subgroup analyses demonstrated an association between H. pylori infection and childhood growth in European, American and Asian subjects, but not in African and Oceanian subjects. The association was also identified in studies with a H. pylori prevalence of ≤50%, but not in studies with a H. pylori prevalence of >50%. A potential explanation for these differences may be different H. pylori prevalence, as well as different environmental and nutritional factors in different countries and regions. Other factors associated with the high prevalence of H. pylori infection and delayed growth in children are linked to the socio-economic development of the population, which is associated with limited health care resources, insufficient nutrition and a poor living environment, which may have influenced the results obtained (53-57).

Furthermore, only cross-sectional and case-control studies indicated that H. pylori infection was associated with delayed growth in children. An improvement in diet and living conditions during the long-term follow-up of cohort studies may impact the outcome. In addition, the 13C-UBT and serum IgG antibodies targeted against H. pylori detection methods suggested that H. pylori infection was associated with delayed growth in children. Although 13C-UBT effectively detects H. pylori infection (58), the detection method has a high rate of false-positives in children aged <6 years (59). A relevant study reported that detection of H. pylori using serum IgG antibodies displayed 88.4% sensitivity and 93.4% specificity compared with histology (60). Anti-H. pylori IgG and IgA antibody titers are higher in children with CagA-positive sera regardless of their age. Therefore, serum IgG or IgA antibodies are recommended for the detection of H. pylori in asymptomatic children aged <6 years (61). Non-invasive screening methods may be used for children aged >6 years based on different situations, while children with adverse gastrointestinal symptoms, including peptic ulcers and dyspepsia, should be evaluated by upper gastrointestinal endoscopy for the diagnosis of associated pathology (62). Consistent with the conclusion proposed by Chilengi et al (44), the subgroup analysis performed in the present study suggested that there was a significant association between H. pylori infection and delayed linear childhood growth, regardless of whether or not the potential confounders had been adjusted.

However, the present study had a number of limitations. First, although only medium- and high-quality studies were included, the 15 observational studies were of lower quality than randomized controlled trial which may have affected the objectivity of the major outcomes. Furthermore, delayed childhood growth in the included studies was defined using different guidelines, resulting in different ranges of percentiles or 1-3 standard deviations. These criteria may have overlapped; therefore, they were not distinguished in the subgroup analyses. In addition, the age, growth rate and hormone levels of each group of children may have been different in each study, which may have further impacted the results of the present study. As another possible limitation, environmental factors, inter-individual differences and iron deficiency anaemia may also lead to malnutrition in children; therefore, management of the growth and development of H. pylori-positive children should fully consider these comprehensive factors. Finally, omission of relevant published or unpublished studies may have influenced the conclusions made in the present study.

In conclusion, the present study suggested that H. pylori infection increased the likelihood of delayed childhood growth, particularly linear growth. The results suggested that children with delayed linear growth should be actively assessed and treated for H. pylori infection based on their antimicrobial susceptibility profile. Furthermore, it is necessary to establish a uniform standard definition for delayed childhood growth. Once diagnosed, the infection should be treated immediately to avoid further profound effects. Future extensive studies of vaccine strategies for the prevention of H. pylori infection in children are required. Furthermore, future high-quality and well-designed studies should be performed to further investigate the results obtained in the present study.

Acknowledgements

Not applicable.

Funding

The present study was supported by the National Natural Science Foundation of China (grant no. 81770561), the Jiangsu Medical Leading Talent and Innovation Team (grant no. CXTDA2017033) and the Jiangsu Province ‘333’ Project (grant no. BRA2014332).

Availability of data and materials

The datasets used and/or analyzed during the present study are available from the corresponding author on reasonable request.

Authors' contributions

GZ and SW designed the study. SW and YD performed the literature search and extracted the data. LT, LP and XL analyzed the data. SW wrote the manuscript. All authors read and approved the final version of this manuscript.

Ethical approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Khalifa MM, Sharaf RR and Aziz RK: Helicobacter pylori: A poor man's gut pathogen? Gut Pathog. 2(2)2010.PubMed/NCBI View Article : Google Scholar

2 

Engstrand L and Lindberg M: Helicobacter pylori and the gastric microbiota. Best Pract Res Clin Gastroenterol. 27:39–45. 2013.PubMed/NCBI View Article : Google Scholar

3 

Plummer M, Franceschi S, Vignat J, Forman D and de Martel C: Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 136:487–490. 2015.PubMed/NCBI View Article : Google Scholar

4 

Ford AC, Gurusamy KS, Delaney B, Forman D and Moayyedi P: Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database Syst Rev. 4(CD003840)2016.PubMed/NCBI View Article : Google Scholar

5 

Yamaoka Y: Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol. 7:629–641. 2010.PubMed/NCBI View Article : Google Scholar

6 

Hudak L, Jaraisy A, Haj S and Muhsen K: An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia. Helicobacter. 22:2017.PubMed/NCBI View Article : Google Scholar

7 

Kalach N, Bontems P, Koletzko S, Mourad-Baars P, Shcherbakov P, Celinska-Cedro D, Iwanczak B, Gottrand F, Martinez-Gomez MJ, Pehlivanoglu E, et al: Frequency and risk factors of gastric and duodenal ulcers or erosions in children: A prospective 1-month European multicenter study. Eur J Gastroenterol Hepatol. 22:1174–1181. 2010.PubMed/NCBI View Article : Google Scholar

8 

Bontems P, Kalach N, Vanderpas J, Iwanczak B, Casswall T, Koletzko S, Oderda G, Martinez-Gomez MJ, Urruzuno P, Kindermann A, et al: Helicobacter pylori infection in European children with gastro-duodenal ulcers and erosions. Pediatr Infect Dis J. 32:1324–1329. 2013.PubMed/NCBI View Article : Google Scholar

9 

McColl KE and el-Omar E: Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer. Scand J Gastroenterol Suppl. 215:32–37. 1996.PubMed/NCBI View Article : Google Scholar

10 

Dror G and Muhsen K: Helicobacter pylori infection and children's growth: An overview. J Pediatr Gastroenterol Nutr. 62:e48–e59. 2016.

11 

Yang YJ, Sheu BS, Yang HB, Lu CC and Chuang CC: Eradication of Helicobacter pylori increases childhood growth and serum acylated ghrelin levels. World J Gastroenterol. 18:2674–2681. 2012.PubMed/NCBI View Article : Google Scholar

12 

Jones NL, Koletzko S, Goodman K, Bontems P, Cadranel S, Casswall T, Czinn S, Gold BD, Guarner J, Elitsur Y, et al: Joint ESPGHAN/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents (Update 2016). J Pediatr Gastroenterol Nutr. 64:991–1003. 2017.PubMed/NCBI View Article : Google Scholar

13 

Silva GM, Silva HM, Nascimento J, Goncalves JP, Pereira F and Lima R: Helicobacter pylori antimicrobial resistance in a pediatric population. Helicobacter. 23(e12528)2018.PubMed/NCBI View Article : Google Scholar

14 

Velin D, Straubinger K and Gerhard M: Inflammation, immunity, and vaccines for Helicobacter pylori infection. Helicobacter. 21 (Suppl 1):S26–S29. 2016.PubMed/NCBI View Article : Google Scholar

15 

Okuda M, Nomura K, Kato M, Lin Y, Mabe K, Miyamoto R, Okumura A and Kikuchi S: Gastric cancer in children and adolescents in Japan. Pediatr Int. 61:80–86. 2019.PubMed/NCBI View Article : Google Scholar

16 

WHO Multicentre Growth Reference Study Group: WHO child growth standards based on length/height, weight and age. Acta Paediatr Suppl 450: 76.85, 2006.

17 

de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C and Siekmann J: Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 85:660–667. 2007.PubMed/NCBI View Article : Google Scholar

18 

Benavides-Ward A, Vasquez-Achaya F, Silva-Caso W, Aguilar-Luis MA, Mazulis F, Urteaga N and Del Valle-Mendoza J: Helicobacter pylori and its relationship with variations of gut microbiota in asymptomatic children between 6 and 12 years. BMC Res Notes. 11(468)2018.PubMed/NCBI View Article : Google Scholar

19 

Thomas JE, Dale A, Bunn JE, Harding M, Coward WA, Cole TJ and Weaver LT: Early Helicobacter pylori colonisation: The association with growth faltering in The Gambia. Arch Dis Child. 89:1149–1154. 2004.PubMed/NCBI View Article : Google Scholar

20 

Perri F, Pastore M, Leandro G, Clemente R, Ghoos Y, Peeters M, Annese V, Quitadamo M, Latiano A, Rutgeerts P and Andriulli A: Helicobacter pylori infection and growth delay in older children. Arch Dis Child. 77:46–49. 1997.

21 

Fialho AM, Braga AB, Queiroz DM, Rodrigues MN, Herbster ID and Braga LL: The association between Helicobacter pylori infection and height in children from an urban community in north-east Brazil. Ann Trop Paediatr. 27:55–61. 2007.PubMed/NCBI View Article : Google Scholar

22 

Patel P, Mendall MA, Khulusi S, Northfield TC and Strachan DP: Helicobacter pylori infection in childhood: Risk factors and effect on growth. BMJ. 309:1119–1123. 1994.PubMed/NCBI View Article : Google Scholar

23 

Taşar A, Kibrisli E and Dallar Y: Seroprevalence of Helicobacter pylori in children with constitutional height retardation. Turk J Gastroenterol. 17:7–12. 2006.PubMed/NCBI

24 

Liu WZ, Xie Y, Lu H, Cheng H, Zeng ZR, Zhou LY, Chen Y, Wang JB, Du YQ, Lu NH, et al: Fifth Chinese national consensus report on the management of Helicobacter pylori infection. Helicobacter. 23(e12475)2018.PubMed/NCBI View Article : Google Scholar

25 

Bunn JE, Thomas JE, Harding M, Coward WA and Weaver LT: Placental acquisition of maternal specific IgG and Helicobacter pylori colonization in infancy. Helicobacter. 8:568–572. 2003.PubMed/NCBI View Article : Google Scholar

26 

Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA and Thacker SB: Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 283:2008–2012. 2000.PubMed/NCBI View Article : Google Scholar

27 

Moher D, Liberati A, Tetzlaff J and Altman DG: PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int J Surg. 8:336–341. 2010.PubMed/NCBI View Article : Google Scholar

28 

Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 25:603–605. 2010.PubMed/NCBI View Article : Google Scholar

29 

Hu J, Dong Y, Chen X, Liu Y, Ma D, Liu X, Zheng R, Mao X, Chen T and He W: Prevalence of suicide attempts among Chinese adolescents: A meta-analysis of cross-sectional studies. Compr Psychiatry. 61:78–89. 2015.PubMed/NCBI View Article : Google Scholar

30 

Higgins JP, Thompson SG, Deeks JJ and Altman DG: Measuring inconsistency in meta-analyses. BMJ. 327:557–560. 2003.PubMed/NCBI View Article : Google Scholar

31 

Belachew A and Tewabe T: Neonatal sepsis and its association with birth weight and gestational age among admitted neonates in Ethiopia: Systematic review and meta-analysis. BMC Pediatr. 20(55)2020.PubMed/NCBI View Article : Google Scholar

32 

Raymond J, Bergeret M, Benhamou PH, Mensah K and Dupont C: A 2-year study of Helicobacter pylori in children. J Clin Microbiol. 32:461–463. 1994.PubMed/NCBI

33 

Choe YH, Kim SK and Hong YC: Helicobacter pylori infection with iron deficiency anaemia and subnormal growth at puberty. Arch Dis Child. 82:136–140. 2000.PubMed/NCBI View Article : Google Scholar

34 

Lin X: Study on risk factors of Helicobacter pylori infection and the effect of Helicobacter pylori infection on iron status and growth among preschool children (vol. Master). Fujian Med Univ. pp65:2002.

35 

Cherian S, Forbes D, Sanfilippo F, Cook A and Burgner D: Helicobacter pylori, helminth infections and growth: A cross-sectional study in a high prevalence population. Acta Paediatr. 98:860–864. 2009.PubMed/NCBI View Article : Google Scholar

36 

Gulcan M, Ozen A, Karatepe HO, Gulcu D and Vitrinel A: Impact of H. pylori on growth: Is the infection or mucosal disease related to growth impairment? Dig Dis Sci. 55:2878–2886. 2010.

37 

Mendoza E, Camorlinga-Ponce M, Perez-Perez G, Mera R, Vilchis J, Moran S, Rivera O, Coria R, Torres J, Correa P and Duque X: Present and past Helicobacter pylori infection in Mexican school children. Helicobacter. 19:55–64. 2014.PubMed/NCBI View Article : Google Scholar

38 

Janjetic MA, Mantero P, Cueto RE, Balcarce N, Zerbetto de Palma G, Catalano M, Zubillaga MB, Boccio JR and Goldman CG: Dietary and anthropometric indicators of nutritional status in relation to Helicobacter pylori infection in a paediatric population. Br J Nutr. 113:1113–1119. 2015.PubMed/NCBI View Article : Google Scholar

39 

Oderda G, Palli D, Saieva C, Chiorboli E and Bona G: Short stature and Helicobacter pylori infection in italian children: Prospective multicentre hospital based case-control study. The Italian study group on short stature and H. pylori. BMJ. 317:514–515. 1998.PubMed/NCBI View Article : Google Scholar

40 

Cacciari E, Menegatti M, Salardi S, Ali A, Stella FA, Figura N, Landi F, Holton J, Farinelli S, Cuccaro V, et al: Helicobacter pylori infection and cytotoxic antigen associated gene ‘A’ status in short children. J Pediatr Endocrinol Metab. 12:197–201. 1999.

41 

Büyükgebiz A, Dündar B, Böber E and Büyükgebiz B: Helicobacter pylori infection in children with constitutional delay of growth and puberty. J Pediatr Endocrinol Metab. 14:549–551. 2001.PubMed/NCBI View Article : Google Scholar

42 

Takahashi M, Kimura H and Watanabe K: Helicobacter pylori infection in patients with idiopathic short stature. Pediatr Int. 44:277–280. 2002.PubMed/NCBI View Article : Google Scholar

43 

Chiu NC, Lin CY, Chi H, Yeung CY, Ting WH, Chan WT, Jiang CB, Li ST, Lin CH and Lee HC: Helicobacter pylori infection is not associated with failure to thrive: A case control study. Ther Clin Risk Manag. 13:273–278. 2017.PubMed/NCBI View Article : Google Scholar

44 

Chilengi R, Asombang M, Kadota JL, Chilyabanyama ON, Mwila-Kazimbaya K, Ng'Ombe H, Simuyandi M and Bosomprah S: Early linear growth retardation: Results of a prospective study of Zambian infants. Bmc Public Health. 19(61)2019.PubMed/NCBI View Article : Google Scholar

45 

Queiroz DM, Rocha AM and Crabtree JE: Unintended consequences of Helicobacter pylori infection in children in developing countries: Iron deficiency, diarrhea, and growth retardation. Gut Microbes. 4:494–504. 2013.PubMed/NCBI View Article : Google Scholar

46 

Ortiz-Princz D, Daoud G, Salgado-Sabel A and Cavazza ME: Helicobacter pylori infection in children: Should it be carefully assessed? Eur Rev Med Pharmacol Sci. 20:1798–1813. 2016.PubMed/NCBI

47 

Wroblewski LE and Peek RJ Jr: Helicobacter pylori in gastric carcinogenesis: Mechanisms. Gastroenterol Clin North Am. 42:285–298. 2013.PubMed/NCBI View Article : Google Scholar

48 

Serrano C, Wright SW, Bimczok D, Shaffer CL, Cover TL, Venegas A, Salazar MG, Smythies LE, Harris PR and Smith PD: Downregulated Th17 responses are associated with reduced gastritis in Helicobacter pylori-infected children. Mucosal Immunol. 6:950–959. 2013.PubMed/NCBI View Article : Google Scholar

49 

Muhsen K, Ornoy A, Akawi A, Alpert G and Cohen D: An association between Helicobacter pylori infection and cognitive function in children at early school age: A community-based study. BMC Pediatr. 11(43)2011.PubMed/NCBI View Article : Google Scholar

50 

Bazmamoun H, Rafeey M, Nikpouri M and Ghergherehchi R: Helicobacter pylori infection in children with type 1 diabetes mellitus: A case-control study. J Res Health Sci. 16:68–71. 2016.PubMed/NCBI

51 

Xiong LJ and Mao M: Current views of the relationship between Helicobacter pylori and Henoch-Schonlein purpura in children. World J Clin Pediatr. 5:82–88. 2016.PubMed/NCBI View Article : Google Scholar

52 

Dehghani SM, Karamifar H, Raeesi T and Haghighat M: Growth parameters in children with dyspepsia symptoms and Helicobacter pylori infection. Indian Pediatr. 50:324–326. 2013.PubMed/NCBI View Article : Google Scholar

53 

Asgeirsdottir GA, Kjartansdottir I, Olafsdottir AS, Hreinsson JP, Hrafnkelsson H, Johannsson E and Bjornsson ES: Helicobacter pylori infection in Icelandic children. Scand J Gastroenterol. 52:686–690. 2017.PubMed/NCBI View Article : Google Scholar

54 

Nakayama Y, Lin Y, Hongo M, Hidaka H and Kikuchi S: Helicobacter pylori infection and its related factors in junior high school students in Nagano Prefecture, Japan. Helicobacter. 22:2017.PubMed/NCBI View Article : Google Scholar

55 

Shu X, Ping M, Yin G and Jiang M: Investigation of Helicobacter pylori infection among symptomatic children in Hangzhou from 2007 to 2014: A retrospective study with 12,796 cases. PeerJ. 5(e2937)2017.PubMed/NCBI View Article : Google Scholar

56 

Awuku YA, Simpong DL, Alhassan IK, Tuoyire DA, Afaa T and Adu P: Prevalence of helicobacter pylori infection among children living in a rural setting in Sub-Saharan Africa. Bmc Public Health. 17(360)2017.PubMed/NCBI View Article : Google Scholar

57 

Koletzko S, Jones NL, Goodman KJ, Gold B, Rowland M, Cadranel S, Chong S, Colletti RB, Casswall T, Elitsur Y, et al: Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 53:230–243. 2011.PubMed/NCBI View Article : Google Scholar

58 

Ferwana M, Abdulmajeed I, Alhajiahmed A, Madani W, Firwana B, Hasan R, Altayar O, Limburg PJ, Murad MH and Knawy B: Accuracy of urea breath test in Helicobacter pylori infection: Meta-analysis. World J Gastroenterol. 21:1305–1314. 2015.PubMed/NCBI View Article : Google Scholar

59 

Leal YA, Flores LL, Fuentes-Pananá EM, Cedillo-Rivera R and Torres J: 13C-urea breath test for the diagnosis of Helicobacter pylori infection in children: A systematic review and meta-analysis. Helicobacter. 16:327–337. 2011.PubMed/NCBI View Article : Google Scholar

60 

Raj P, Thompson JF and Pan DH: Helicobacter pylori serology testing is a useful diagnostic screening tool for symptomatic inner city children. Acta Paediatr. 106:470–477. 2017.PubMed/NCBI View Article : Google Scholar

61 

Seo JH, Lim CW, Park JS, Yeom JS, Lim JY, Jun JS, Woo HO, Youn HS, Baik SC, Lee WK, et al: Correlations between the CagA antigen and serum levels of anti-Helicobacter pylori IgG and IgA in children. J Korean Med Sci. 31:417–422. 2016.PubMed/NCBI View Article : Google Scholar

62 

Romano C, Valenti S, Cardile S and Benninga MA: Functional dyspepsia: An enigma in a conundrum. J Pediatr Gastroenterol Nutr. 63:579–584. 2016.PubMed/NCBI View Article : Google Scholar

Related Articles

Journal Cover

June-2020
Volume 19 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wei S, Dang Y, Peng L, Li X, Tang L and Zhang G: Association between Helicobacter pylori infection and delayed growth in children: A meta‑analysis. Exp Ther Med 19: 3814-3828, 2020
APA
Wei, S., Dang, Y., Peng, L., Li, X., Tang, L., & Zhang, G. (2020). Association between Helicobacter pylori infection and delayed growth in children: A meta‑analysis. Experimental and Therapeutic Medicine, 19, 3814-3828. https://doi.org/10.3892/etm.2020.8654
MLA
Wei, S., Dang, Y., Peng, L., Li, X., Tang, L., Zhang, G."Association between Helicobacter pylori infection and delayed growth in children: A meta‑analysis". Experimental and Therapeutic Medicine 19.6 (2020): 3814-3828.
Chicago
Wei, S., Dang, Y., Peng, L., Li, X., Tang, L., Zhang, G."Association between Helicobacter pylori infection and delayed growth in children: A meta‑analysis". Experimental and Therapeutic Medicine 19, no. 6 (2020): 3814-3828. https://doi.org/10.3892/etm.2020.8654